Stay updated on Propranolol and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Propranolol and Pembrolizumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added. The government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding status notice banner was added and the page revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedMinor UI and metadata updates were made, including adding a glossary toggle and new labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while related items like 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now lists revision v3.3.4, replacing the previous v3.3.3 revision at the bottom of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing Georgia, New York, Ohio, and Pennsylvania, and removed the separate Georgia Locations, New York Locations, Ohio Locations, and Pennsylvania Locations subsections.SummaryDifference0.5%

- Check85 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2; no study details, navigation, or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Propranolol and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Propranolol and Pembrolizumab in Melanoma Clinical Trial page.